| Financier | Commitments |
|---|---|
| IDA Grant | 2.20 |
| IDA Grant | 2.20 |
Additional Financing for the Guinea-Bissau COVID-19 Vaccine Project
Abstract*
The proposed Project will support the Government of Guinea-Bissau efforts to further strengthen its response to COVID-19 pandemic by purchasing COVID-19 vaccines, preparing the immunization system for the deployment of the COVID-19 vaccine, and supporting the distribution of these vaccines. The proposed project will strengthen the national immunization and related health delivery system in a way that will promote an effective COVID-19 response and... Show More
Development Objective
The Project Development Objective is to prevent, detect and response to the threat posed by COVID-19 and strengthen national systems for public health preparedness in Guinea-Bissau.
Key Details
Project Details
P178198
Active
Fatoumata Barry , Yemdaogo Tougma
Republic of Guinea Bissau,Republic of Guinea Bissau
December 12, 2021
(as of board presentation)
December 23, 2021
N/A
US$ 2.20 million
Office of the High Commissioner for COVID-19,Office of the High Commissioner for COVID-19
2022
US$ 2.20 million
N/A
N/A
June 30, 2024
No
BANK APPROVED
November 8, 2022
Finances
Financing Plan (US$ Millions)
Total Project Financing (US$ Millions)
| Product Line | IBRD/IDA |
|---|---|
| IBRD Commitment | N/A |
| IDA Commitment | 2.20 |
| IBRD + IDA Commitment | 2.20 |
| Lending Instrument | |
|---|---|
| Grant Amount | N/A |
| Total Project Cost** | 2.20 |
Summary Status of World Bank Financing (US$ Millions) as of March 31, 2025
No data available.
Detailed Financial Activity as of March 31, 2025
No data available.
Results Framework
No data available.